Precision Medicine for Prostate Cancer — AI can help patients decide whether active surveillance is right for them
The multimodal ArteraAI Prostate Testopens in a new tab or window (AI Test) is currently the only test that provides insights [...]
Diagnexia and Artera Partner to Bring Groundbreaking AI Prostate Test to the UK
Diagnexia, the UK’s leading provider of AI-powered digital pathology diagnostic services, is thrilled to announce an exclusiv [...]
The 4 step process to achieve AI data locality while serving AI globally
As part of Artera’s mission to improve patient outcomes globally, Artera launched a highly successful product for patients wi [...]
5 Common Myths That Accompany a Cancer Diagnosis
Receiving a cancer diagnosis can be the most terrifying moment of your life. It may feel as though your world is caving in ar [...]
Tempus Partners with Artera to Expand Personalized Prostate Cancer Treatment
Tempus, a leader in using artificial intelligence (AI) to advance precision medicine connected to over half of all practicing [...]
Andre Esteva Named 40 Under 40 by Modern Healthcare
Many of this year’s 40 Under 40 honorees were motivated to pursue a career in healthcare by watching family members navigate [...]
Optimizing Kubernetes Log Aggregation: Tackling Fluent Bit Buffering and Backpressure Challenges
At Artera, we rely on Kubernetes (EKS) clusters to run applications, with Fluent Bit handling log forwarding to DataDog for m [...]
Are Open Source Pathology Foundation Models ready for the clinic?
Imagine that a pathologist reads a slide and diagnoses a patient’s cancer on a Monday. They return a few weeks later, read th [...]
AI significantly improves risk classification for prostate cancer metastasis
An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach [...]